Clinical and Applied Thrombosis/Hemostasis : Impact Factor & More

eISSN: 1938-2723pISSN: 1076-0296
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Clinical and Applied Thrombosis/Hemostasis Key Metrics

CiteScore
4
H-Index
59
Impact Factor
< 5
SJR
Q2Hematology
SNIP
1.05
Time to Accept
2
 Mo
Time to Publish
time-to-publish View Chart
3
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
45%
4 to 6 months
49%
7 to 9 months
6%
Above 9 months
0%

Topics Covered on Clinical and Applied Thrombosis/Hemostasis

Clinical and Applied Thrombosis/Hemostasis Journal Specifications

Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2500
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Clinical and Applied Thrombosis/Hemostasis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Applied Thrombosis/Hemostasis

A Novel Non-invasive Marker for Predicting Mechanical Prosthetic Heart Valve Thrombosis: Red Cell Distribution Width to Platelet Ratio
  • 1 Apr 2025
  • Clinical and Applied Thrombosis/Hemostasis
Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation.
  • 1 Mar 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Clopidogrel Management in Abdominal Surgery: A Comparison of Perioperative Bleeding Risks with Low-Molecular-Weight Heparin Bridging, No-Bridging and Clopidogrel Continuation Strategies.
  • 1 Mar 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban.
  • 1 Feb 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Immature Platelets and Platelet Reactivity in Patients with COVID-19.
  • 1 Feb 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
A Novel Non-invasive Marker for Predicting Mechanical Prosthetic Heart Valve Thrombosis: Red Cell Distribution Width to Platelet Ratio
  • 1 Apr 2025
  • Clinical and Applied Thrombosis/Hemostasis
Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation.
  • 1 Mar 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Clopidogrel Management in Abdominal Surgery: A Comparison of Perioperative Bleeding Risks with Low-Molecular-Weight Heparin Bridging, No-Bridging and Clopidogrel Continuation Strategies.
  • 1 Mar 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban.
  • 1 Feb 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Immature Platelets and Platelet Reactivity in Patients with COVID-19.
  • 1 Feb 2025
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Compare Similar Journals with Clinical and Applied Thrombosis/Hemostasis

Select Journals to Compare with Clinical and Applied Thrombosis/Hemostasis
Total journals - 9
You can select up to 3 Journals at a time

Thrombosis Research

Publisher: PERGAMON-ELSEVIER SCIENCE LTD

Thrombosis and Haemostasis

Publisher: GEORG THIEME VERLAG KG

Journal of Thrombosis and Haemostasis

Publisher: ELSEVIER SCIENCE INC

Journal of Thrombosis and Thrombolysis

Publisher: SPRINGER

Blood

Publisher: AMER SOC HEMATOLOGY

Medicine

Publisher: Elsevier

European Heart Journal

Publisher: OXFORD UNIV PRESS

Journal of Clinical Medicine

Publisher: MDPI

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE
0 Journals Selected to compare with
Clinical and Applied Thrombosis/Hemostasis
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in Clinical and Applied Thrombosis/Hemostasis?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Clinical and Applied Thrombosis/Hemostasis